awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45066717-4F9DC585-E3AE-48B7-B3FE-E8E1290E75A0
Q45066717-4F9DC585-E3AE-48B7-B3FE-E8E1290E75A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45066717-4F9DC585-E3AE-48B7-B3FE-E8E1290E75A0
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.
P2860
Q45066717-4F9DC585-E3AE-48B7-B3FE-E8E1290E75A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45066717-4F9DC585-E3AE-48B7-B3FE-E8E1290E75A0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0ba67953186f83db5fc64d00b28f3f20112c43ad
P2860
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group